PL207337A1 - Sposob wytwarzania pochodnych ftalazyny - Google Patents
Sposob wytwarzania pochodnych ftalazynyInfo
- Publication number
- PL207337A1 PL207337A1 PL20733778A PL20733778A PL207337A1 PL 207337 A1 PL207337 A1 PL 207337A1 PL 20733778 A PL20733778 A PL 20733778A PL 20733778 A PL20733778 A PL 20733778A PL 207337 A1 PL207337 A1 PL 207337A1
- Authority
- PL
- Poland
- Prior art keywords
- phthalasin
- derivatives
- production
- phthalasin derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2358277 | 1977-06-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL207337A1 true PL207337A1 (pl) | 1979-06-04 |
| PL113208B1 PL113208B1 (en) | 1980-11-29 |
Family
ID=10198020
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1978217897A PL116437B1 (en) | 1977-06-03 | 1978-06-02 | Process for preparing novel phthalazine derivatives |
| PL1978217896A PL116420B1 (en) | 1977-06-03 | 1978-06-02 | Process for preparing novel phthalazine derivatives |
| PL1978207337A PL113208B1 (en) | 1977-06-03 | 1978-06-02 | Process for preparing novel phthalazine derivatives |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1978217897A PL116437B1 (en) | 1977-06-03 | 1978-06-02 | Process for preparing novel phthalazine derivatives |
| PL1978217896A PL116420B1 (en) | 1977-06-03 | 1978-06-02 | Process for preparing novel phthalazine derivatives |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US4289772A (pl) |
| JP (1) | JPS5416488A (pl) |
| AR (2) | AR222013A1 (pl) |
| AT (2) | AT362792B (pl) |
| AU (1) | AU505373B1 (pl) |
| BE (1) | BE867727A (pl) |
| CA (1) | CA1111850A (pl) |
| DD (1) | DD137355A5 (pl) |
| DE (1) | DE2824064A1 (pl) |
| DK (1) | DK248078A (pl) |
| EG (1) | EG13527A (pl) |
| ES (4) | ES470470A1 (pl) |
| FI (1) | FI781753A7 (pl) |
| FR (1) | FR2392986A1 (pl) |
| GB (1) | GB2000136B (pl) |
| GR (1) | GR74402B (pl) |
| HU (1) | HU179745B (pl) |
| IL (1) | IL54842A (pl) |
| IN (3) | IN148482B (pl) |
| IT (1) | IT1094944B (pl) |
| LU (1) | LU79761A1 (pl) |
| NL (1) | NL7806016A (pl) |
| NO (1) | NO781935L (pl) |
| NZ (1) | NZ187453A (pl) |
| PL (3) | PL116437B1 (pl) |
| PT (1) | PT68126A (pl) |
| SE (1) | SE7806519L (pl) |
| SU (2) | SU856383A3 (pl) |
| ZA (1) | ZA783183B (pl) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
| IL59619A0 (en) * | 1979-03-28 | 1980-06-30 | Pfizer | Phthalazine derivatives,their preparation and pharmaceutical compositions containing them |
| ES499716A0 (es) * | 1980-03-01 | 1982-05-01 | Wyeth John & Brother Ltd | Un procedimiento para la preparacion de nuevos derivados de piperidina |
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| US5001125A (en) * | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| US4882354A (en) * | 1987-12-16 | 1989-11-21 | Norwich Eaton Pharmaceuticals, Inc. | N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents |
| JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
| US5300515A (en) * | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
| EP0621267A1 (en) * | 1993-04-07 | 1994-10-26 | Shell Internationale Researchmaatschappij B.V. | Spiropiperidine derivatives and their use as fungicides |
| WO1996036611A1 (en) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
| NZ333354A (en) * | 1996-08-20 | 2000-05-26 | Eisai Co Ltd | Fused pyridazine compounds for erectile dysfunction |
| US20030186963A1 (en) | 2001-09-14 | 2003-10-02 | Dorwald Florencio Zaragoza | Substituted piperidines |
| JP4554364B2 (ja) * | 2002-08-16 | 2010-09-29 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | インテグリンと選択的に結合するピペリジニル化合物 |
| US20040224986A1 (en) * | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
| US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
| TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| CA2635439A1 (en) * | 2006-01-27 | 2007-08-02 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| WO2007110449A1 (en) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
| WO2007118853A1 (en) | 2006-04-13 | 2007-10-25 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use as blockers of calcium channels |
| TW200812963A (en) | 2006-04-13 | 2008-03-16 | Euro Celtique Sa | Benzenesulfonamide compounds and the use thereof |
| CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
| EP1900731A1 (de) * | 2006-09-07 | 2008-03-19 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren |
| WO2008030651A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
| CN101778837A (zh) | 2007-08-07 | 2010-07-14 | 弗·哈夫曼-拉罗切有限公司 | 作为nk3受体拮抗剂的吡咯烷芳基-醚 |
| ATE519738T1 (de) | 2007-08-22 | 2011-08-15 | Hoffmann La Roche | Pyrrolidinarylether als nk3-rezeptorantagonisten |
| MX2010002585A (es) * | 2007-09-14 | 2010-03-26 | Hoffmann La Roche | Derivados de piperidina como antagonistas del receptor nk3. |
| US8765736B2 (en) | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| AR077014A1 (es) * | 2009-06-19 | 2011-07-27 | Lilly Co Eli | Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| WO2022081661A1 (en) | 2020-10-13 | 2022-04-21 | Endeavor Biomedicines, Inc. | Methods of treating fibrosis |
| CN113087654B (zh) * | 2021-04-15 | 2022-12-23 | 苏州昊帆生物股份有限公司 | 哌啶-4-丁胺的制备方法 |
| WO2025188802A1 (en) | 2024-03-05 | 2025-09-12 | Endeavor Biomedicines, Inc. | Methods of improving lung function |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1094044A (en) * | 1965-07-12 | 1967-12-06 | Vantorex Ltd | Phthalazine derivatives |
| GB1199768A (en) | 1966-10-31 | 1970-07-22 | Pfizer & Co C | Nitrogen Heterocycles and process for their preparation |
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
| GB1460389A (en) | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
-
1978
- 1978-05-15 IN IN364/DEL/78A patent/IN148482B/en unknown
- 1978-06-01 NZ NZ187453A patent/NZ187453A/xx unknown
- 1978-06-01 GR GR56414A patent/GR74402B/el unknown
- 1978-06-01 IT IT24106/78A patent/IT1094944B/it active
- 1978-06-01 GB GB7826202A patent/GB2000136B/en not_active Expired
- 1978-06-01 JP JP6627978A patent/JPS5416488A/ja active Granted
- 1978-06-01 DE DE19782824064 patent/DE2824064A1/de not_active Ceased
- 1978-06-01 PT PT68126A patent/PT68126A/pt unknown
- 1978-06-01 FI FI781753A patent/FI781753A7/fi not_active Application Discontinuation
- 1978-06-01 BE BE188257A patent/BE867727A/xx unknown
- 1978-06-01 IL IL54842A patent/IL54842A/xx unknown
- 1978-06-02 DD DD78205751A patent/DD137355A5/xx unknown
- 1978-06-02 PL PL1978217897A patent/PL116437B1/pl unknown
- 1978-06-02 NO NO781935A patent/NO781935L/no unknown
- 1978-06-02 HU HU78PI629A patent/HU179745B/hu unknown
- 1978-06-02 AT AT0400878A patent/AT362792B/de not_active IP Right Cessation
- 1978-06-02 SE SE7806519A patent/SE7806519L/xx unknown
- 1978-06-02 DK DK248078A patent/DK248078A/da not_active Application Discontinuation
- 1978-06-02 ES ES470470A patent/ES470470A1/es not_active Expired
- 1978-06-02 FR FR7816545A patent/FR2392986A1/fr active Granted
- 1978-06-02 AR AR272434A patent/AR222013A1/es active
- 1978-06-02 NL NL7806016A patent/NL7806016A/xx not_active Application Discontinuation
- 1978-06-02 LU LU79761A patent/LU79761A1/fr unknown
- 1978-06-02 CA CA304,700A patent/CA1111850A/en not_active Expired
- 1978-06-02 ZA ZA00783183A patent/ZA783183B/xx unknown
- 1978-06-02 AU AU36839/78A patent/AU505373B1/en not_active Expired
- 1978-06-02 SU SU782624349A patent/SU856383A3/ru active
- 1978-06-02 PL PL1978217896A patent/PL116420B1/pl unknown
- 1978-06-02 PL PL1978207337A patent/PL113208B1/pl unknown
- 1978-06-03 EG EG354/78A patent/EG13527A/xx active
-
1979
- 1979-03-01 ES ES478201A patent/ES478201A1/es not_active Expired
- 1979-03-01 ES ES478199A patent/ES478199A1/es not_active Expired
- 1979-03-01 ES ES478200A patent/ES478200A1/es not_active Expired
- 1979-06-18 SU SU792777649A patent/SU862826A3/ru active
- 1979-12-13 US US06/103,342 patent/US4289772A/en not_active Expired - Lifetime
-
1980
- 1980-02-12 AR AR279935A patent/AR223999A1/es active
- 1980-05-20 IN IN368/DEL/80A patent/IN149550B/en unknown
- 1980-06-10 AT AT0305080A patent/AT363096B/de not_active IP Right Cessation
-
1981
- 1981-01-13 IN IN19/DEL/81A patent/IN149973B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL207337A1 (pl) | Sposob wytwarzania pochodnych ftalazyny | |
| PL204549A1 (pl) | Sposob wytwarzania pochodnych pirolidyny | |
| PL207396A1 (pl) | Sposob wytwarzania nowych pochodnych kwasu penicylanowego | |
| PL204550A1 (pl) | Sposob wytwarzania pochodnych pirolidyny | |
| PL205498A1 (pl) | Sposob wytwarzania pochodnych morfiny | |
| PL210045A1 (pl) | Sposob wytwarzania nowych pochodnych czteropeptydow | |
| PL200685A1 (pl) | Sposob wytwarzania nowych pochodnych uracylu | |
| PL204134A1 (pl) | Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych | |
| PL204616A1 (pl) | Sposob wytwarzania pochodnych 1-oksadetiacefamowych | |
| PL205592A1 (pl) | Sposob wytwarzania nitrozobenzenu | |
| PL205497A1 (pl) | Sposob wytwarzania nowych pochodnych morfiny | |
| PL206456A1 (pl) | Sposob wytwarzania pochodnych pirydazynonu-3 | |
| PL208318A1 (pl) | Sposob wytwarzania pochodnych tienopirydyny | |
| PL208434A1 (pl) | Sposob wytwarzania nowych pochodnych benzopiranu | |
| PL209256A1 (pl) | Sposob wytwarzania pochodnych kwasu 2-hydrazonopropionowego | |
| PL206833A1 (pl) | Sposob wytwarzania nowych pochodnych 6-aminopenamu | |
| PL197045A1 (pl) | Sposob wytwarzania nowych pochodnych uracylu | |
| PL208436A1 (pl) | Sposob wytwarzania pochodnych bis-(nitrozoureido)-polioli | |
| PL211328A1 (pl) | Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy | |
| PL204428A1 (pl) | Sposob wytwarzania nowych pochodnych erytomycyny | |
| PL211027A1 (pl) | Sposob wytwarzania antybiotyku c-15003-p4 | |
| PL209049A1 (pl) | Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy | |
| PL209122A1 (pl) | Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu | |
| PL204551A1 (pl) | Sposob wytwarzania nowych pochodnych kwasu benzoheterocykloglioksalowego | |
| PL204212A1 (pl) | Sposob wytwarzania pochodnych p-nitrozodwufenylohydroksyloaminy |